Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma With Multiple Atypical Metastatic Sites.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
02 Oct 2024
02 Oct 2024
Historique:
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
2
10
2024
Statut:
aheadofprint
Résumé
The development of late metastatic recurrence after nephrectomy is a well-known characteristic of renal cell carcinoma (RCC). Correct diagnosis is often challenging due to the long time between primary tumor excision and the development of metastases. 68Ga-DOTATATE PET/CT has the potential to be employed in the follow-up of RCC, because RCC expresses somatostatin receptors. However, limited cases have been reported demonstrating 68Ga-DOTATATE uptake in the metastases of RCC. Herein, we describe a unique case of RCC with multiple atypical metastatic sites, emphasizing the usefulness of 68Ga-DOTATATE PET/CT in the evaluation and follow-up of patients with RCC.
Identifiants
pubmed: 39354688
doi: 10.1097/RLU.0000000000005493
pii: 00003072-990000000-01303
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Schey C, Meier G, Pan J. Metastatic renal cell cancer: an analysis of reimbursement decisions. Adv Ther. 2019;36:1266–1278.
Park HK. The metastasis pattern of renal cell carcinoma is influenced by histologic subtype, grade, and sarcomatoid differentiation. Medicina (Kaunas). 2023;59:1845.
Villarreal-Garza C, Perez-Alvarez SI, Gonzalez-Espinoza IR, et al. Unusual metastases in renal cell carcinoma: a single institution experience and review of literature. World J Oncol. 2010;1:149–157.
Singla A, Sharma U, Makkar A, et al. Rare metastatic sites of renal cell carcinoma: a case series. Pan Afr Med J. 2022;42:26.
Piskorz Ł, Mitura K, Olejniczak W, et al. Atypical locations of renal cell carcinoma metastases to the pancreas and duodenum. Res Rep Urol. 2021;13:17–24.
Vamadevan S, Le K, Shen L, et al. 68Ga-DOTATATE uptake in a soft tissue metastasis from clear cell renal cell cancer. Clin Nucl Med. 2018;43:44–45.
Höög A, Kjellman M, Mattsson P, et al. Somatostatin receptor expression in renal cell carcinoma—a new front in the diagnostics and treatment of renal cell carcinoma. Clin Genitourin Cancer. 2018;16:e517–e520.
Guglielmo P, Pesella F, Sartorello A, et al. Metastasis from clear cell renal cell carcinoma mimicking well-differentiated pancreatic neuroendocrine tumor at 18F-FDG and 68Ga-DOTATOC PET/CT. Clin Nucl Med. 2022;47:e498–e499.
Filizoglu N, Ozguven S. Solitary contralateral adrenal metastasis of renal cell carcinoma: 68Ga-DOTATATE PET/CT findings. Clin Nucl Med. 2022;47:e41–e42.
Kanthan GL, Schembri GP, Samra J, et al. Metastatic renal cell carcinoma in the thyroid gland and pancreas showing uptake on 68Ga DOTATATE PET/CT scan. Clin Nucl Med. 2016;41:583–584.
Mansour N, Rangan K, Tiling R, et al. 68Ga-DOTATOC PET/CT in pancreatic metastasis from clear cell renal cell carcinoma. Clin Nucl Med. 2023;48:712–713.